Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. KYMR
KYMR logo

KYMR News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KYMR News

Analysis of KYMR Options Trading Dynamics

Mar 03 2026NASDAQ.COM

Kymera Therapeutics (KYMR.US) Insider Plans to Sell $18.27 Million in Common Stock via Form 144

Mar 02 2026moomoo

Piper Sandler Raises Kymera Price Target to $140 on Strong Clinical Data

Feb 27 2026Yahoo Finance

Kymera Therapeutics Highlights Q4 2025 Earnings Call

Feb 26 2026seekingalpha

Kymera Therapeutics Set to Announce Q4 Earnings

Feb 25 2026seekingalpha

Baker Bros. Advisors Increases Stake in Kymera Therapeutics

Feb 23 2026Fool

Baker Bros. Advisors Increases Stake in Kymera Therapeutics

Feb 23 2026Yahoo Finance

Rock Springs Capital Increases Stake in Kymera Therapeutics

Feb 17 2026Fool

KYMR Events

No data

No data

KYMR Monitor News

Kymera Therapeutics Reports Strong Q4 Progress and New Partnerships

Feb 26 2026

Kymera Therapeutics Hits 52-Week High on KT-621 Trial Results

Dec 08 2025

KYMR Earnings Analysis

No Data

No Data

People Also Watch